GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ambu AS (FRA:547A) » Definitions » EBIT

Ambu AS (FRA:547A) EBIT : €43.8 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Ambu AS EBIT?

Ambu AS's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was €-24.3 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was €43.8 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Ambu AS's annualized ROC % for the quarter that ended in Sep. 2024 was 7.69%. Ambu AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was -33.79%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Ambu AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 1.15%.


Ambu AS EBIT Historical Data

The historical data trend for Ambu AS's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ambu AS EBIT Chart

Ambu AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.06 44.92 18.95 36.34 43.86

Ambu AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.01 17.31 26.56 24.25 -24.28

Competitive Comparison of Ambu AS's EBIT

For the Medical Devices subindustry, Ambu AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ambu AS's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ambu AS's EV-to-EBIT falls into.



Ambu AS EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €43.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ambu AS  (FRA:547A) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Ambu AS's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=78.86 * ( 1 - 25.41% )/( (784.215 + 745.826)/ 2 )
=58.821674/765.0205
=7.69 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=976.484 - 120.721 - ( 71.548 - max(0, 132.109 - 333.221+71.548))
=784.215

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=959.475 - 131.167 - ( 82.482 - max(0, 142.03 - 353.667+82.482))
=745.826

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Ambu AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-97.1/( ( (155.557 + max(134.79, 0)) + (151.15 + max(133.312, 0)) )/ 2 )
=-97.1/( ( 290.347 + 284.462 )/ 2 )
=-97.1/287.4045
=-33.79 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(103.973 + 133.583 + 19.026) - (120.721 + 0 + 1.071)
=134.79

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(99.917 + 144.578 + 20.788) - (131.167 + 0 + 0.804)
=133.312

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Ambu AS's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=43.838/3809.129
=1.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ambu AS EBIT Related Terms

Thank you for viewing the detailed overview of Ambu AS's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Ambu AS Business Description

Address
Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS is a Denmark based company providing single-use flexible endoscopes and is dedicated to optimizing hospital workflows and improving patient care. The company has created medtech solutions like resuscitators, anaesthesia masks, and electrodes and operates R&D, manufacturing and sales in Europe, North America and Rest of the world.

Ambu AS Headlines

No Headlines